Yun Yang

Effective treatment of severe COVID-19 patients with tocilizumab

Xiaohu Zheng, Binqing Fu, Haiming Wei, 2020, Proceedings of the National Academy of Sciences.

Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial

Xiaojing Wang, X. Yao, Binqing Fu, 2021, Frontiers of Medicine.

Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients

Xiaohu Zheng, Binqing Fu, Haiming Wei, 2020, Proceedings of the National Academy of Sciences.

Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention

Xiaohu Zheng, Binqing Fu, Haiming Wei, 2020, Proceedings of the National Academy of Sciences.

High flow nasal cannula is a good treatment option for COVID-19

Yun Yang, A. Pan, Chunyan Zhu, 2020, Heart & Lung.

Tocilizumab Ameliorates the Hypoxia in COVID-19 Moderate Patients with Bilateral Pulmonary Lesions: A Randomized, Controlled, Open-Label, Multicenter Trial

X. Yao, Binqing Fu, Haiming Wei, 2020 .

Clinical characteristics and treatment strategies of 79 patients with COVID-19

Yun Yang, A. Pan, Tian-jun Yang, 2020 .